LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Search

Kymera Therapeutics Inc

Open

Sector Healthcare

47.5 2.33

Overview

Share price change

24h

Current

Min

44.96

Max

47.89

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+15.58 upside

News Sentiment

By Acuity

50%

50%

167 / 390 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Kymera Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

1 lis 2024, 03:00 UTC

Top News

U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners -- WSJ

9 lip 2024, 09:05 UTC

Top News

These Stocks Are Moving the Most Today: Tesla, Corning, BP, Intel, and More -- Barrons.com

Peer Comparison

Price change

Kymera Therapeutics Inc Forecast

Price Target

By TipRanks

15.58% upside

12 Months Forecast

Average 53.71 USD  15.58%

High 74 USD

Low 38 USD

Based on 16 Wall Street analysts offering 12 month price targets forKymera Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

12

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

45.71 / 46.9799Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

167 / 390 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Above average

Financials

$